Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 1—January 2020

Paid Leave and Access to Telework as Work Attendance Determinants during Acute Respiratory Illness, United States, 2017–2018

Faruque Ahmed1Comments to Author , Sara Kim, Mary Patricia Nowalk, Jennifer P. King, Jeffrey J. VanWormer, Manjusha Gaglani, Richard K. Zimmerman, Todd Bear, Michael L. Jackson, Lisa A. Jackson, Emily Martin, Caroline Cheng, Brendan Flannery, Jessie R. Chung, and Amra Uzicanin
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (F. Ahmed, S. Kim, B. Flannery, J.R. Chung, A. Uzicanin); University of Pittsburgh, Pittsburgh, Pennsylvania, USA (M.P. Nowalk, R.K. Zimmerman, T. Bear); Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA (J.P. King, J.J. VanWormer); Texas A&M University, Temple, Texas, USA (M. Gaglani); Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA (M.L. Jackson, L.A. Jackson); University of Michigan, Ann Arbor, Michigan, USA (E. Martin, C. Cheng)

Main Article

Table 2

Work attendance during the first 3 days of illness among adults with medically attended acute respiratory illness or influenza, United States, 2017–18 influenza season*

Work attendance Mean no. days worked
Access to telework
Paid leave benefits
Yes, n = 198 No†, n = 1,164 Yes, n = 1,074 No, n = 282
Worked 1.46‡ 1.09 1.15 1.09
Usual workplace 1.05 1.07 1.07 1.05

Did not work 1.54‡ 1.91 1.85 1.91
Felt ill 0.80‡ 1.10 1.03 1.17
Day off 0.64 0.72 0.72 0.66
Other reasons 0.11 0.10 0.10 0.07

*Days worked or not worked ranged from 0 to 3 days. Boldface indicates statistical significance.
†Among 1,164 persons with no telework access (i.e., did not habitually telework), 15 persons reported that they worked from home for ≥1 d during the first 3 d of illness.

Main Article

1Preliminary results from this study were presented at the International Conference on Emerging Infectious Diseases, August 2729, 2018, Atlanta, Georgia, USA.

Page created: December 18, 2019
Page updated: December 18, 2019
Page reviewed: December 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.